DT

David Thompson

Pfizer: 40 patents #32 of 5,153Top 1%
AL Aristocrat Technologies Australia Pty Limited: 11 patents #88 of 510Top 20%
AR Atlantic Richfield: 5 patents #106 of 1,061Top 10%
📍 Mona Vale, IN: #1 of 1 inventorsTop 100%
Overall (All Time): #38,788 of 4,157,543Top 1%
60
Patents All Time

Issued Patents All Time

Showing 26–50 of 60 patents

Patent #TitleCo-InventorsDate
6610719 Use of prostaglandin (PGE2) receptor a (EP4) selective agonists for the treatment of acute and chronic renal failure Vishwas Paralkar 2003-08-26
6512002 Methods of treatment for premature ejaculation in a male Andrew Lee, Wesley Day 2003-01-28
6492412 Prevention of loss and restoration of bone mass by certain prostaglandin agonists Kimberly O. Cameron, Hua Zhu Ke, Bruce Lefker, Robert L. Rosati 2002-12-10
6436977 Dosing regimens for lasofoxifene 2002-08-20
6426359 Prevention and treatment of skeletal disorder with EP2 receptor subtype selective prostaglandin E2 agonists Kimberly O. Cameron, Hua Zhu Ke, Bruce Lefker, Robert L. Rosati 2002-07-30
6403611 Use of estrogen antagonists and estrogen agonists in inhibiting pathological conditions David B. MacLean 2002-06-11
6355670 Use of estrogen antagonists and estrogen agonists in inhibiting pathological conditions David B. MacLean 2002-03-12
6323232 Combination therapy for osteoporosis Hua Zhu Ke 2001-11-27
6288120 Prevention of loss and restoration of bone mass by certain prostaglandin agonists Kimberly O. Cameron, Hua Zhu Ke, Bruce Lefker, Robert L. Rosati 2001-09-11
6284773 Therapeutic combinations comprising a selective estrogen receptor modulator and prostaglandin E2 HuaZhu Ke 2001-09-04
6274618 Use of estrogen antagonists and estrogen agonists in inhibiting pathological conditions David B. MacLean 2001-08-14
6132774 Therapeutic combinations comprising a selective estrogen receptor modulator and parathyroid hormone HuaZhu Ke 2000-10-17
6107331 Use of estrogen antagonists and estrogen agonists in inhibiting pathological conditions David B. MacLean 2000-08-22
6100301 Combination therapy to treat osteoporosis-polyphosphonates and estrogen agonists David B. MacLean 2000-08-08
6057309 Combination therapy to prevent bone loss-progesterone and estrogen agonists David B. MacLean 2000-05-02
6017964 Method of increasing testosterone David B. MacLean 2000-01-25
5985932 Inhibition of autoimmune diseases David B. MacLean 1999-11-16
5933789 Method and system for applying dispersive normal moveout corrections to seismic survey signals Bok S. Byun, E. Stuart Nelan 1999-08-03
5902830 Use of droloxifene for the treatment of cardiovascular disease Roland Loser, Michael Schliack 1999-05-11
5889042 Method of treating diseases and conditions with estrogen agonists and antagonists David B. MacLean 1999-03-30
5861438 Combination therapy to prevent bone loss parathyroid hormone and estrogen agonists David B. MacLean 1999-01-19
5852059 Use of droloxifene for the treatment of protastic disease, endometriosis and obesity 1998-12-22
5827892 Use of droloxifene for the treatment of cardiovascular diseases Roland Loser, Michael Schliack 1998-10-27
5773477 Combination therapy to treat osteoporosis - polyphosphonates and estrogen agonists David B. MacLean 1998-06-30
5764516 Method and system for surface-consistent phase and time lag correction of seismic data Bok S. Byun 1998-06-09